<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyEventTranscriptSummaryOutput xmlns:ns2="local" id="1119620"><Name>Q3 2005 Cambridge Antibody Technology Earnings Conference Call</Name><Company>AstraZeneca plc</Company><Drugs><Drug>tralokinumab</Drug><Drug>adalimumab</Drug><Drug>fresolimumab</Drug><Drug>lerdelimumab</Drug><Drug>belimumab</Drug></Drugs></ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyEventTranscriptSummaryOutput>